Patent ID: 8589188
Filing Date: 2013-11-19
Classification: A61P,G16H,Y10S

Abstract:
1. A method of distributing a drug to a patient comprising identifying that the patient has disease or condition responsive to a drug that is contraindicated for fetal exposure and permitting the drug to be distributed to the patient by a pharmacy only after the pharmacy has received a prescription wherein generation of the prescription comprises the following steps: (a) via a computer readable storage medium, registering a prescriber and the pharmacy with a distributor of a teratogenic drug; (b) determining whether the patient is able to understand and carry out instructions; (c) upon determination that the patient is able to carry out the instructions, providing verbal and written warnings of the hazard of taking the drug and exposing fetus to the drug; (d) further providing verbal and written warnings of the risk of possible contraception failure and of the need to use barrier contraception when having sexual intercourse with women of child bearing potential; (e) obtaining acknowledgement of said warnings from the patient; (f) via a computer readable storage medium, registering the patient with the distributor; and (g) upon obtaining the acknowledgement and registrations, generating via a computer readable storage medium the prescription to be retrieved by the pharmacy before the drug is distributed.